-
Something wrong with this record ?
Toward structure-based drug design against the epidermal growth factor receptor (EGFR)
Y. Haddad, M. Remes, V. Adam, Z. Heger
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
- MeSH
- ErbB Receptors antagonists & inhibitors chemistry genetics MeSH
- Protein Kinase Inhibitors pharmacology MeSH
- Humans MeSH
- Ligands MeSH
- Mutation MeSH
- Drug Design methods MeSH
- Decision Making MeSH
- Molecular Docking Simulation MeSH
- Binding Sites MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Most of the available crystal structures of epidermal growth factor receptor (EGFR) kinase domain, bound to drug inhibitors, originated from ligand-based drug design studies. Here, we used variations in 110 crystal structures to assemble eight distinct families highlighting the C-helix orientation in the N-lobe of the EGFR kinase domain. The families shared similar mutational profiles and similarity in the ligand R-groups (chemical composition, geometry, and charge) facing the C-helix, mutation sites, and DFG domain. For structure-based drug design, we recommend a systematic decision-making process for choice of template, guided by appropriate pairwise fitting and clustering before the molecular docking step. Alternatively, the binding site shape/volume can be used to filter and select the compound libraries.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004641
- 003
- CZ-PrNML
- 005
- 20220127145108.0
- 007
- ta
- 008
- 220113s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.drudis.2020.10.007 $2 doi
- 035 __
- $a (PubMed)33075469
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Haddad, Yazan $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czech Republic; Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, 612 00 Brno, Czech Republic
- 245 10
- $a Toward structure-based drug design against the epidermal growth factor receptor (EGFR) / $c Y. Haddad, M. Remes, V. Adam, Z. Heger
- 520 9_
- $a Most of the available crystal structures of epidermal growth factor receptor (EGFR) kinase domain, bound to drug inhibitors, originated from ligand-based drug design studies. Here, we used variations in 110 crystal structures to assemble eight distinct families highlighting the C-helix orientation in the N-lobe of the EGFR kinase domain. The families shared similar mutational profiles and similarity in the ligand R-groups (chemical composition, geometry, and charge) facing the C-helix, mutation sites, and DFG domain. For structure-based drug design, we recommend a systematic decision-making process for choice of template, guided by appropriate pairwise fitting and clustering before the molecular docking step. Alternatively, the binding site shape/volume can be used to filter and select the compound libraries.
- 650 _2
- $a vazebná místa $7 D001665
- 650 _2
- $a rozhodování $7 D003657
- 650 _2
- $a racionální návrh léčiv $x metody $7 D015195
- 650 _2
- $a erbB receptory $x antagonisté a inhibitory $x chemie $x genetika $7 D066246
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a simulace molekulového dockingu $7 D062105
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a inhibitory proteinkinas $x farmakologie $7 D047428
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Remes, Marek $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czech Republic; Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, 612 00 Brno, Czech Republic
- 700 1_
- $a Adam, Vojtech $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czech Republic; Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, 612 00 Brno, Czech Republic
- 700 1_
- $a Heger, Zbynek $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czech Republic; Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, 612 00 Brno, Czech Republic. Electronic address: heger@mendelu.cz
- 773 0_
- $w MED00173737 $t Drug discovery today $x 1878-5832 $g Roč. 26, č. 2 (2021), s. 289-295
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33075469 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127145105 $b ABA008
- 999 __
- $a ok $b bmc $g 1751949 $s 1155790
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 26 $c 2 $d 289-295 $e 20201017 $i 1878-5832 $m Drug discovery today $n Drug Discov Today Dis Mech $x MED00173737
- LZP __
- $a Pubmed-20220113
